Company Filing History:
Years Active: 2025
Title: Innovations by Anna Reister Schultz in Acute Myeloid Leukemia Treatment
Introduction
Anna Reister Schultz is a notable inventor based in Beaverton, OR (US). She has made significant contributions to the field of medical research, particularly in the treatment of acute myeloid leukemia (AML). Her work focuses on developing methods to treat AML in the presence of gene mutations, which is a critical area of study in oncology.
Latest Patents
Anna holds a patent for her invention titled "Treatments for mutations in acute myeloid leukemia." This patent outlines useful methods for treating AML in humans, specifically targeting cases where gene mutations are present. Her innovative approach aims to improve treatment outcomes for patients suffering from this challenging disease. She has 1 patent to her name.
Career Highlights
Anna is affiliated with Oregon Health & Science University, where she conducts her research and develops her inventions. Her work is instrumental in advancing the understanding and treatment of AML, contributing to the broader field of cancer research.
Collaborations
Throughout her career, Anna has collaborated with esteemed colleagues such as Jeffrey Tyner and Cristina Tognon. These partnerships enhance her research efforts and contribute to the development of effective treatment strategies.
Conclusion
Anna Reister Schultz is a pioneering inventor whose work in treating acute myeloid leukemia represents a significant advancement in medical science. Her dedication to improving patient outcomes through innovative treatments is commendable.